IVF Earnings Date & History
INVO Fertility Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:18 PM ET
INVO Fertility Inc
Health Care
- Next earnings date
- Monday, November 16, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.66
- Revenue estimate
- $2.7M
IVF earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Monday, June 22, 2026 | Q1 2026 | $-1.26 | $-3.38 | -167.7% | $2.0M |
| Tuesday, June 2, 2026 | Q4 2025 | $-2.78 | $-196.81 | -6985.9% | $1.6M |
| Monday, November 17, 2025 | Q3 2025 | $-0.04 | $-0.77 | -1805.9% | $1.8M |
What the market is watching in IVF's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next IVF earnings date?
- INVO Fertility Inc is scheduled to report on Monday, November 16, 2026 (Time TBD). Dates can change until the company confirms them.
- Does IVF report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for IVF?
- Consensus EPS for the upcoming quarter is $-0.66, on revenue of $2.7M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
IVF earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.